Metraipolis › archive › dc_e201d4ea8e26

Remodelling of cystic fibrosis respiratory microbiota in response to extended elexacaftor-tezacaftor-ivacaftor therapy — Europe PMC PMID:42218569

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42218569
DOI
10.1186/s40168-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-01T01:23:50.176Z
SHA-256 of the archived text
48f40b724ffb68201c82655ae71ad3248bb8cd7eed676d5d1c437aec4e71be9b
Stable URL of this page
https://metraipolis.com/documento/dc_e201d4ea8e26

How to cite

Remodelling of cystic fibrosis respiratory microbiota in response to extended elexacaftor-tezacaftor-ivacaftor therapy — Europe PMC PMID:42218569 — Europe PMC (en), https://europepmc.org/article/MED/42218569 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e201d4ea8e26 (Metraipolis archive dc_e201d4ea8e26, sha256 48f40b724ffb68201c82655ae71ad3248bb8cd7eed676d5d1c437aec4e71be9b)
BibTeX
@misc{dce201d4ea8e26,
  title = {Remodelling of cystic fibrosis respiratory microbiota in response to extended elexacaftor-tezacaftor-ivacaftor therapy — Europe PMC PMID:42218569},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42218569},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e201d4ea8e26; sha256 48f40b724ffb68201c82655ae71ad3248bb8cd7eed676d5d1c437aec4e71be9b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42218569. Agents can read the archived copy with the MCP tool read_document.